Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof

Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof

US Patent 11833209 · Granted Dec 5, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulated and/or co-formulated liposome compositions containing toll-like recep2025
Formulated and/or co-formulated liposome compositions containing toll-like recep2025
Formulated and/or co-formulated liposome compositions containing toll-like recep2025
Formulated and/or co-formulated liposome compositions containing toll-like recep2025
Formulated and/or co-formulated liposome compositions containing IDO antagonist 2025
Formulated and/or co-formulated liposome compositions containing IDO antagonist 2025
Formulated and/or co-formulated liposome compositions containing IDO antagonist 2025
Formulated and/or co-formulated liposome compositions containing IDO antagonist 2025
Population control using engineered translocations2025
Fusion protein composition(s) comprising masked type i interferons (IFNA and IFN2024
DNA sequence modification-based gene drive2024
Formulated and/or co-formulated liposome compositions containing PD-1 antagonist2024